U.S. CBP implements new duties on Chinese imports
Effective May 2, 2025
U.S. Customs and Border Protection (CBP) today issued an amended notice regarding the implementation of additional duties on products from China, including Hong Kong. This action follows the April 2 Executive Order 14256, which addresses the synthetic opioid supply chain and eliminates the de minimis exemption for low-value imports from China. Read TradeNewsFlash
Effective May 2, 2025, products from China and Hong Kong valued at or under $800 will no longer qualify for duty-free de minimis treatment. Instead, they will be subject to either a 120% ad valorem duty or a specific duty of $100 per postal item, increasing to $200 on June 1, 2025. These duties apply to goods sent through the international postal network.
CBP will modify the Harmonized Tariff Schedule of the United States (HTSUS) to reflect these changes, ensuring all applicable duties are collected. Carriers must collect and remit the duties, and international carrier bonds are required to secure duty payments.
Background
On January 20, 2025, a national emergency was declared due to the threat posed by illegal drugs and aliens entering the United States. The scope was expanded on February 1, 2025, to include China’s failure to control chemical precursor suppliers and other criminal activities. As a result, ad valorem tariffs were imposed on Chinese imports. Read TradeNewsFlash